The Art of Innovation: Clinical Development of Trastuzumab Deruxtecan and Redefining How Antibody-Drug Conjugates Target HER2-Positive Cancers
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
7
Citations
NaN
KQI